- West Pharmaceutical Services, Inc. is a leading manufacturer of high-quality packaging components and delivery systems for injectable drugs, with a market capitalization of $23.1 billion and annual revenue of $3.0 billion as of 2025.
- In 2025, West reported a 6.3% increase in full-year net sales to $3.074 billion and announced a new share repurchase program of up to $1 billion, reflecting strong cash flow generation and improving margins.
- The company serves established and emerging drug developers globally, delivering billions of components and devices annually, and has recently expanded its Dublin facility to support high-volume injectable therapies for diabetes and obesity.
- West's ideal buyers are pharmaceutical and biotechnology companies seeking reliable and innovative solutions for injectable drug delivery, addressing the critical need for safe and effective containment of life-saving medications.
West Pharmaceutical Services operates with a streamlined departmental structure comprising three key areas. The largest departments include Education and Information Technology, each with a headcount of one, while the 'Other' category encompasses seven employees. This distribution indicates a focused operational model with a significant concentration of resources in specialized functions, highlighting the company's strategic emphasis on niche expertise.
The company's workforce is distributed across two primary locations, with Coral Springs, FL, and Grand Rapids, MI, each accounting for one employee. The majority of the workforce, categorized under 'Other,' suggests a decentralized operational model, allowing for flexibility and adaptation to various market needs. This geographic distribution reflects a strategic approach to resource allocation across diverse regions.
